tiprankstipranks
Trending News
More News >

Acotec Scientific Gains Approval for New Vascular Device in China

Story Highlights
Acotec Scientific Gains Approval for New Vascular Device in China

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Acotec Scientific Holdings Limited ( (HK:6669) ).

Acotec Scientific Holdings Limited announced that it has received approval from the PRC National Medical Products Administration for its new product, the E-Peridge® Peripheral Scoring Balloon Dilatation Catheter. This device is designed to aid in the pre-dilation of stenotic lesions in peripheral vessels, enhancing vessel preparation for subsequent treatments. The approval marks a significant step in Acotec’s product development and market expansion efforts in China, although the company cautions that successful marketing of the product is not guaranteed.

More about Acotec Scientific Holdings Limited

Acotec Scientific Holdings Limited, incorporated in the Cayman Islands, operates in the medical device industry, focusing on developing innovative products for vascular intervention. The company’s primary products include devices for the treatment and management of vascular diseases, with a market focus on the People’s Republic of China (PRC).

Average Trading Volume: 303,398

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$2.69B

For a thorough assessment of 6669 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1